SCHEMBL408305

SCHEMBL408305

Clc1ccccc1-c1nc2c(s1)CCCC2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.52
RAB9A P51151 7/20 0.52
MAPT P10636 6/20 0.52
HPGD P15428 5/20 0.52
NPC1 O15118 5/20 0.52
KDM4E B2RXH2 5/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
LMNA P02545 3/20 0.52
NPSR1 Q6W5P4 2/20 0.52
GAA P10253 2/20 0.52
GLA P06280 1/20 0.52
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20329029 0.85 PDCD1 (0.47) ALDH1A1RAB9AMAPTHPGDNPC1
Bromide SCHEMBL437878 0.78 PDCD1 (0.54) ALDH1A1RAB9AMAPTHPGDNPC1
SCHEMBL6223472 0.77 ALDH1A1 (0.49) ALDH1A1RAB9AMAPTHPGDNPC1
SCHEMBL17332419 0.76 NPC1 (0.51) ALDH1A1RAB9AMAPTHPGDNPC1
SCHEMBL3109463 0.75 LMNA (0.50) ALDH1A1RAB9AMAPTHPGDNPC1
SCHEMBL18711325 0.72 GRM5 (0.57) RAB9AMAPTNPC1KMT2ATP53
SCHEMBL12731740 0.70 ALDH1A1 (0.38) ALDH1A1RAB9AMAPTHPGDNPC1
SCHEMBL13382632 0.69 RAB9A (0.48) ALDH1A1RAB9AMAPTHPGDNPC1
SCHEMBL2098418 0.67 ALDH1A1 (0.49) ALDH1A1RAB9AMAPTHPGDNPC1
SCHEMBL2095718 0.67 ALDH1A1 (0.45) ALDH1A1RAB9AMAPTHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120065196-A1 AMIDE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065196-A1 AMIDE COMPOUNDS DGAT2, DGAT1, DLAT ALDH1A1 272/4885RAB9A 1525/4885MAPT 1464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.